NORLASE is an emerging global ophthalmic medical device company developing next-generation laser solutions for the treatment of retina and glaucoma disease. NORLASE is comprised of worldwide industry leaders and experts in ophthalmology, laser technology, medical device development and customer care.
NORLASE develops next-generation laser solutions for the treatment of retina and glaucoma diseases. Founded in Denmark, NORLASE is comprised of worldwide industry experts in ophthalmology, laser technology, medical device development, and customer care.
NORLASE is on a mission to improve practice efficiency, patient care, and physician convenience for ophthalmologists worldwide. NORLASE products include its flagship product LEAF, a laser photocoagulator that’s 10X smaller than existing systems and mounts directly on the slit lamp, and LION – the first fully integrated green laser and LIO.
Oliver Hvidt - CEO